Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

There’s new evidence that Larotrectinib (Vitrakvi), by Loxo Oncology and Bayer, is highly effective in children with newly diagnosed infantile fibrosarcoma (IFS) or other solid tumors.

Read more: https://www.insideprecisionmedicine.com/topics/oncology/infantile-fibrosarcoma-and-other-solid-tumors-respond-well-to-precision-medicine/